Vertaling van "al analysis " (Frans → Nederlands) :

Actuarial Analysis; Insurance, Liability; Malpractice, Blood Transfusion
Costs and Cost Analysis; Cross Infection; Hospital Mortality; Infection Control; Length of Stay

Spontaneous cessation rate: 2.5% OR counselling only: 1.73 Incremental OR NRT gum (relative to counselling only): 1.63 Incremental OR NRT patch (relative to counselling only): 1.79 Incremental OR NRT spray (relative to counselling only): 2.35 Incremental OR NRT inhaler (relative to counselling only): 2.14 Incremental OR Buproprion (relative to counselling only): 2.30 % of smokers still under treatment after the first month: 50% (range 40-60% in sensitivity analysis) % of smokers still under treatment after the second month: 20% (range 15-25% in sensitivity analysis) Lifetime relapse probability after one year of abstinence: 35% (range 10-50% in sensitivity analysis) Effect of smoking cessation on mortality derived from the results of the American Cancer Society Prevention Study II. The mortality rate for former smokers was projected by calculating a weighted average of the incremental differentials between mortality rates of neversmokers and smokers, weighted according to the duration of abstinence.
Spontaneous cessation rate: 2.5% OR counselling only: 1.73 Incremental OR NRT gum (relative to counselling only): 1.63 Incremental OR NRT patch (relative to counselling only): 1.79 Incremental OR NRT spray (relative to counselling only): 2.35 Incremental OR NRT inhaler (relative to counselling only): 2.14 Incremental OR bupropion (relative to counselling only): 2.30 % of smokers still under treatment after the first month: 50% (range 40-60% in sensitivity analysis) % of smokers still under treatment after the second month: 20% (range 15-25% in sensitivity analysis) Lifetime relapse probability after one year of abstinence: 35% (range 10-50% in sensitivity analysis) Effect of smoking cessation on mortality derived from the results of the American Cancer Society Prevention Study II. The mortality rate for former smokers was projected by calculating a weighted average of the incremental differentials between mortality rates of neversmokers and smokers, weighted according to the duration of abstinence.

Le Comité scientifique constate qu’en ce qui concerne les aspects statistiques des dossiers de validation du Milkoscan FT 6000 et du Fossomatic FC, il a notamment été fait référence aux normes ISO 13366-2 « Milk – Enumeration of somatic cells – Part 2 : Guidance on the operation of fluoro-opto-electronic counters » et ISO 8196-3 « Milk – Definition and evaluation of the overall accuracy of indirect and alternative methods of milk analysis – Part 3 : Protocol for the evaluation and validation of alternative quantitative methods of milk analysis ».
Het Wetenschappelijk Comité stelt vast dat voor wat de statistische aspecten van de validatiedossiers van de Milkoscan FT 6000 en van de Fossomatic FC betreft, er met name verwezen werd naar de normen ISO 13366-2 « Milk – Enumeration of somatic cells – Part 2 : Guidance on the operation of fluoro-opto-electronic counters » en ISO 8196-3 « Milk – Definition and evaluation of the overall accuracy of indirect and alternative methods of milk analysis – Part 3 : Protocol for the evaluation and validation of alternative quantitative methods of milk analysis ».

Table 9: Evidence form systematic reviews and meta analysis (breast cancer mortality reduction in intervention group) Study ID Ref Population Intervention Results of meta-analysis Comments Level of evidence
Table 7: Evidence form systematic reviews and meta analysis (breast cancer mortality reduction in intervention group) Study ID Ref Population Intervention Results of meta-analysis Comments Level of evidence

Table 3: Search for SR and MA Search Benefit and harms of mammography screening (40-49 y) questions Note Specific search for systematic reviews and meta-analysis Date 19/04/2010 Keywords Breast neoplasms (MESH) and mass screening (or early detection) (MESH) and mammography (MESH) Medline 1 meta-analysis.pt,ti,ab,sh (34320) 27 (1 duplicate) (OVID): 2 1 or (meta anal$ or metaanal$).ti,ab,sh (43943) Filter 3 (methodol$ or systematic$ or quantitativ$).ti,ab,sh.
Table 1: Search for SR and MA Search Benefit and harms of mammography screening (40-49 y) questions Note Specific search for systematic reviews and meta-analysis Date 19/04/2010 Keywords Breast neoplasms (MESH) and mass screening (or early detection) (MESH) and mammography (MESH) Medline 1 meta-analysis.pt,ti,ab,sh (34320) 27 (1 duplicate) (OVID): 2 1 or (meta anal$ or metaanal$).ti,ab,sh (43943) Filter 3 (methodol$ or systematic$ or quantitativ$).ti,ab,sh.

Table 10: Evidence form HTA review : Breast cancer screening among women aged 40 – 49 Relative risks (intention to treat) with confidence reported for each study together with the results of a stepwise meta-analysis and cumulative CI Study ID Relative risk Confidence interval Cumulative RR Cumutlative CI UK Age Trial (UK) 0,83 (0,66-1,04) 0,83 (0,66-1,04) NBSS-1 (Canada) 0,97 (0,74-1,27) 0,89 (0,75-1,06) Malmö (Sweden) (0,58-1,77) 0,9 (0,76-1,06) Stockholm (Sweden) 1,08 (0,54-2,17) 0,91 (0,77-1,07) Göteborg (Sweden) 0,65 (0,40-1,05) 0,87 (0,75-1,02) HIP (USA) 0,75 (0,50-1,11) 0,86 (0,74-0,99) TCS (Sweden) 0,93 (0,63-1,36) 0,86 (0,75-0,99) Edinburgh (UK) 0,75 (0.48-1,18) 0,85 (0,75-0,97)
Table 8: Evidence form HTA review : Breast cancer screening among women aged 40 – 49 Relative risks (intention to treat) with confidence reported for each study together with the results of a stepwise meta-analysis and cumulative CI Study ID Relative risk Confidence interval Cumulative RR Cumutlative CI UK Age Trial (UK) 0,83 (0,66-1,04) 0,83 (0,66-1,04) NBSS-1 (Canada) 0,97 (0,74-1,27) 0,89 (0,75-1,06) Malmö (Sweden) (0,58-1,77) 0,9 (0,76-1,06) Stockholm (Sweden) 1,08 (0,54-2,17) 0,91 (0,77-1,07) Göteborg (Sweden) 0,65 (0,40-1,05) 0,87 (0,75-1,02) HIP (USA) 0,75 (0,50-1,11) 0,86 (0,74-0,99) TCS (Sweden) 0,93 (0,63-1,36) 0,86 (0,75-0,99) Edinburgh (UK) 0,75 (0.48-1,18) 0,85 (0,75-0,97)

Table 17: False positive and false negative mammography results (KCE table) Review Study Type of study Findings Range Mushlin et al, 1998 meta‐ analysis probability of false positive screening per screening 0,9 % to 6,5 % Olivotto et al, 1998 Hofvind et al, 2004 Elmore et al, 1998 Elmore et al, 1998 observational
Table 15: False positive and false negative mammography results (KCE table) Review Study Type of study Findings Range Mushlin et al, 1998 meta‐ analysis probability of false positive screening per screening 0,9 % to 6,5 % Olivotto et al, 1998 Hofvind et al, 2004 Elmore et al, 1998 Elmore et al, 1998 observational

§ 2. Pour la sécurité des denrées alimentaires le système d'autocontrôle doit être basé sur les principes suivants du système de " Hazard analysis and critical control points" (système HACCP) : 1° l'identification de tout danger qu'il y a lieu d'éviter, d'éliminer ou de ramener à un
§ 2. Voor de veiligheid van levensmiddelen moet het autocontrolesysteem gebaseerd zijn op de volgende principes van het “Hazard analysis and critical control points-systeem” (HACCP-systeem): 1° het identificeren van elk gevaar dat voorkomen, geëlimineerd of tot een aanvaardbaar niveau gereduceerd moet worden; 2° het identificeren van de kritische controlepunten in het stadium of de stadia waarin controle essentieel is om een gevaar te voorkomen of te elimineren dan wel tot een aanvaardbaar niveau te reduceren; 3° het vaststellen van kritische grenswaarden voor de kritische controlepunten teneinde te kunnen bepalen wat al dan niet aanvaardbaar is op het vlak van preventie, eliminatie of reductie van een onderkend gevaar; 4° het vaststellen en toepassen van efficiënte bewakingsprocedures voor de kritische controlepunten;

HACCP : Hazard analysis and critical control point system
HACCP : Hazard Analysis and Critical Control Point

In this case the intent-to-treat analysis can give unrealistically narrow confidence intervals if substantial numbers of patients elect to have the treatment they were not randomized to receive 22 .
In this case the intent-to-treat analysis can give unrealistically narrow confidence intervals if substantial numbers of patients elect to have the treatment they were not randomized to receive 21 .